Dr. Mark Lebwohl graduated summa cum laude from Columbia College in 1974 and graduated from Harvard Medical School in 1978. He completed residencies in internal medicine and dermatology, both at Mount Sinai. Dr. Lebwohl has been practicing dermatology since 1983. He is professor and chairman of the Kimberly and Eric J. Waldman Department of Dermatology of the Icahn School of Medicine at Mount Sinai. Dr. Lebwohl is the President of the American Academy of Dermatology. Dr. Lebwohl is chairman emeritus of the Medical Board of the National Psoriasis Foundation. He is the founding editor of Psoriasis Forum as well as a medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. He is editor of the Dermatology Section of Scientific American Medicine. Dr. Lebwohl has chaired numerous symposia and has written, edited, or co-edited several books including Psoriasis, Mild-to-Moderate Psoriasis, and Moderate-to-Severe Psoriasis. He has authored or co-authored over 500 publications including peer-reviewed articles, invited articles and book chapters. Dr. Lebwohl is actively involved in clinical trials of many new dermatologic treatments.
Osteopathic Dermatology in an Allopathic World
- Practice management
- Legislative, regulatory, or organizational changes effecting patient care.
“The Future of Dermatology Practices” Dermatology World, 2014 March.
“Dermatology Incorporated” Dermatology World, 2012 August.
“Building Our Advocacy Arm’s Muscle” Dermatology World, 2015 August.
“Dermatology’s Advocacy Achievements are No Accident” Dermatology World, 2015 July.
Core Competencies: 5, 6, 7
Disclosures: AbGenomics, AbbVie, Amgen, Anacor, Aqua, Canfite Biopharma, Celgene, Clinuvel, Coronado Biosciences, Ferdale, Lilly, Janssen Biotech, Leo Pharmaceuticals, Merz, Novartis, Pfizer, Sandoz, Valeant